Important note

This AI stock analysis for Ginkgo Bioworks Holdings is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Ginkgo Bioworks Holdings - AI Stock Analysis

Analysis generated December 3, 2024

Ginkgo Bioworks Holdings is a biotechnology company that specializes in using bioengineering to develop organism-based synthetic biology. The company engineers and produces custom organisms for applications across a wide array of industries, including agriculture, pharmaceuticals, and energy. Their objective is to make biology easier to engineer and bring to market.

Fundamental Analysis

Revenue for the last quarter was $88 million. This is an impressive increase of 56.93% compared to the quarter before it, indicating robust growth. Moreover, comparing to the same quarter last year, there is an increase of 25.20%, suggesting consistent year-over-year growth.

The net income for the last quarter was $56 million, an outstanding increase of 74.03% compared to the previous quarter. Additionally, when compared to the same quarter last year, there is an impressive increase of 81.38%, further showcasing strong financial health.

EBITDA for the last quarter stood at $38 million, which is an expansion of 81.50% compared to the preceding quarter, and an 85.67% increase compared to the same quarter last year, another positive indicator of growth. Nonetheless, it raises a red flag that there have been several company insiders selling their stock, which is typically interpreted as a bearish signal.

Technical Analysis

The stock price today stands at $9.73, which is an increase of 25.55% compared to a month ago, indicating a positive short-term trend. However, when compared to a year ago, there is a significant decrease of 82.63%, which could be a cause for long-term concern.

The trend currently remains bullish. The current 10-day Simple Moving Average (SMA10) is $8.52, which is higher than the previous SMA10 of $8.27. This implies a potential upward trend in price movement. The Relative Strength Index (RSI) is at 68, suggesting a neutral condition which does not indicate overbought or oversold conditions.

Alternative Data Analysis

Based on job postings and employee sentiment, Ginkgo Bioworks Holdings has 1 open position. This number is down by 75% in the last couple of months, indicating the company may be aiming to improve margins or cut costs, not a very positive sign for a nascent tech-driven company.

Employee sentiment is low, with only 12% of employees having a positive business outlook. Furthermore, this business outlook has declined by 29% in the last couple of months, raising concerns about internal morale and future company performance.

Looking at customer acquisition, Ginkgo Bioworks Holdings has approximately 45,000 visitors to their website, a number that has decreased by 21% over the last couple of months. This could indicate a potential loss in customer interest or market penetration.

Regarding customer engagement, Ginkgo Bioworks Holdings maintains 12,000 followers on their Instagram page and 34,000 followers on their Twitter page, with no significant changes in the last few months. This stability in social media following implies consistent but static engagement.

Moreover, the AltIndex AI score for Ginkgo Bioworks Holdings is 45, which suggests a hold signal based on combined fundamental, technical, and alternative data analyses.

Conclusion

Given the positive quarterly and yearly growth in revenue, net income, and EBITDA for Ginkgo Bioworks Holdings, there is a strong fundamental basis for considering this stock. The technical indicators currently suggest a mild upward trend. However, alternative data, including declining employee sentiment and customer engagement, signify potential challenges ahead.

Balancing all available data, a prudent recommendation would be to hold Ginkgo Bioworks Holdings stock. It appears to have solid growth potential, yet also exhibits warning signs that merit careful attention and ongoing monitoring.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.